Demographic and clinical data
| No. | Age (yr) | Sex | Histology | Level | Dose (Gy) | Fractions | Response |
|---|---|---|---|---|---|---|---|
| 1 | 57 | F | Renal cell carcinoma | L1 | 24 | 1 | OPP |
| 3 | 55 | M | Renal cell carcinoma | L4 | 24 | 1 | SD |
| 4 | 54 | F | Renal cell carcinoma | T12 | 24 | 1 | PD |
| 5 | 52 | M | Renal cell carcinoma | L1 | 27 | 3 | PR |
| 8 | 52 | M | Renal cell carcinoma | L4 | 30 | 5 | PD |
| 9 | 42 | M | Renal cell carcinoma | T11 | 30 | 5 | SD |
| 11 | 53 | F | Renal cell carcinoma | T12 | 30 | 5 | PR |
| 12 | 60 | F | Breast carcinoma | T8 | 30 | 5 | SD |
| 13 | 63 | F | Melanoma | L1 | 27 | 3 | SD |
| 15 | 58 | M | Basal cell carcinoma | T4 | 30 | 5 | PD |
| 16 | 32 | F | Thyroid carcinoma | L3 | 30 | 5 | SD |
| 17 | 46 | F | Thyroid carcinoma | L1 | 27 | 3 | PR |
| L2 | 27 | 3 | SD | ||||
| 18 | 50 | F | Thyroid carcinoma | T11 | 27 | 3 | SD |
| 19 | 49 | M | Thyroid carcinoma | T6 | 27 | 3 | PD |
| 20 | 44 | F | Sarcoma | C3 | 27 | 3 | PR |
| 22 | 50 | F | Sarcoma | T8 | 27 | 3 | SD |
| 23 | 70 | F | Sarcoma | L2 | 27 | 3 | PR |
| 24 | 49 | M | Thyroid carcinoma | T1 | 27 | 3 | SD |
| 25 | 48 | F | Breast carcinoma | T2 | 18 | 1 | PR |
| 26 | 51 | F | Breast carcinoma | T5 | 18 | 1 | SD |
| 27 | 38 | F | Lung carcinoma | L1 | 18 | 1 | SD |
| 29 | 74 | M | Lung carcinoma | L1 | 18 | 1 | OPP |
| 30 | 35 | M | Sarcoma | T8 | 16 | 1 | PR |
| 31 | 50 | F | Sarcoma | T5 | 18 | 1 | PD |
| 32 | 59 | M | Sarcoma | T5 | 18 | 1 | SD |
| 35 | 44 | M | Renal cell carcinoma | L4 | 24 | 1 | PD |
| 36 | 63 | M | Renal cell carcinoma | L6 | 24 | 1 | OPP |
| 37 | 70 | M | Renal cell carcinoma | T12 | 24 | 1 | OPP |
| 38 | 65 | M | Renal cell carcinoma | C3 | 24 | 1 | PR |
| 39 | 61 | M | Renal cell carcinoma | T6 | 27 | 3 | PD |
| 40 | 33 | F | Breast carcinoma | L4 | 27 | 3 | PD |
| 41 | 67 | M | Colon carcinoma | L3 | 27 | 3 | PR |
| 42 | 48 | F | Adenoid cystic carcinoma | C2 | 27 | 3 | PD |
| 43 | 58 | F | Thyroid carcinoma | L2 | 27 | 3 | PR |
| 44 | 34 | F | Breast carcinoma | T9 | 16 | 1 | PR |
| 45 | 65 | M | Prostate carcinoma | T6 | 16 | 1 | OPP |
Note:—SD indicates stable disease.